Related by context. All words. (Click for frequent words.) 78 alvespimycin 78 oral ridaforolimus 78 PNP inhibitor 77 oral prodrug 76 MAGE A3 ASCI 76 vidofludimus 75 SPRYCEL ® 75 R#/MEM # 75 HGS# 75 sorafenib tablets 75 INCB# [001] 75 Panzem R NCD 75 OMNARIS HFA 75 YONDELIS 75 elotuzumab 74 phase IIb clinical 74 Ozarelix 74 refractory gout 74 metaglidasen 74 HCD# [002] 74 Phase IIb clinical trials 74 visilizumab 74 ELACYT 74 CR# vcMMAE 74 HGS ETR1 74 ORENCIA ® 74 refractory chronic lymphocytic 74 evaluating tivozanib 74 ZOLINZA 74 CIMZIA TM 74 TBC# 74 ACTEMRA TM 74 BCX# 74 docetaxel Taxotere ® 74 phase IIb trial 74 docetaxel Taxotere R 74 Traficet EN 74 AEG# 74 Bezielle 74 lintuzumab SGN 74 lomitapide 74 BENLYSTA ® 73 Cimzia TM 73 recurrent glioblastoma multiforme 73 LymphoStat B TM 73 CTAP# Capsules 73 cilengitide 73 Phase IIb trials 73 Tarceva TM 73 oral methylnaltrexone 73 rALLy clinical trial 73 PHX# 73 Phase #b/#a clinical 73 Phase IIIb clinical 73 IMA# 73 GAMMAGARD 73 generation purine nucleoside 73 neratinib 73 antibody MAb 73 APTIVUS 73 Panzem R 73 FOLOTYN ® 73 CYT# potent vascular disrupting 73 receptor tyrosine kinase inhibitor 73 Phase 2a trial 73 HuMax EGFr 73 enzastaurin 73 PEG SN# 73 BRIM2 73 phase Ib 73 acyclovir Lauriad R 73 CEQ# 73 relapsed MM 73 PRTX 73 trastuzumab DM1 T DM1 73 orally administered inhibitor 73 Proellex TM 73 Allovectin 7 R 73 pomalidomide 72 Phase Ib II 72 CIMZIA TM certolizumab pegol 72 systemic RNAi therapeutic 72 sunitinib malate 72 Perforomist ™ Inhalation Solution 72 Cloretazine 72 Bicifadine 72 CCR5 mAb 72 alkylating agent 72 velafermin 72 adalimumab Humira 72 EOquin TM 72 brivaracetam 72 mertansine 72 TELINTRA 72 opioid induced bowel dysfunction 72 PXD# 72 oral rivaroxaban 72 oral deforolimus 72 HGS ETR2 72 cutaneous T 72 MGd 72 talactoferrin 72 registrational trial 72 deforolimus 72 Virulizin ® 72 metastatic hormone refractory 72 Forodesine HCl 72 eniluracil 72 OHR/AVR# 72 budesonide foam 72 ularitide 72 riociguat 72 thetreatment 72 Insegia 72 Ixempra 72 hyperphenylalaninemia HPA due 72 ORENCIA R 72 Plicera 72 immunomodulatory therapy 72 PDE4 inhibitor 72 oral salmon calcitonin 72 galiximab 72 non nucleoside inhibitor 72 ganetespib 72 Pazopanib 72 Archexin 72 pertuzumab 72 Altastaph 72 AZILECT R 72 THALOMID 72 Peginterferon alfa 2b 72 Civacir 72 tanespimycin 72 Zemplar Capsules 72 lumiliximab 71 Amrubicin 71 Kamada AAT 71 ascending dose 71 LymphoStat B belimumab 71 Aflibercept 71 ALN PCS 71 PSMA ADC 71 BAY #-# 71 dose cohort 71 torezolid phosphate 71 alfa 2a 71 maximally tolerated dose 71 Phase Ib study 71 relapsing remitting MS RRMS 71 nitazoxanide 71 R sorafenib tablets 71 paclitaxel Taxol ® 71 HQK 71 Allovectin 7 71 Clolar ® 71 Elagolix 71 FROVA 71 albiglutide 71 Ophena TM 71 CRMD# 71 treatment naive genotype 71 Allovectin 7 ® 71 OncoVEX GM CSF 71 CIMZIA ™ 71 CCR9 antagonist 71 novel VDA molecule 71 Chemophase 71 Dacogen injection 71 JAK inhibitor 71 Phase 1b trial 71 nucleotide analog 71 rindopepimut 71 PANVAC VF 71 Hsp# Inhibitor 71 HuMax CD4 71 mapatumumab 71 Zenvia ™ 71 PDX pralatrexate 71 LEP ETU 71 regorafenib 71 virus HCV protease inhibitor 71 PROMACTA 71 Fibrillex TM 71 acetonide FA 71 intranasal formulation 71 ZACTIMA 71 #I TM# 71 GALNS 71 canakinumab 71 dextofisopam 71 ONTAK 71 protease inhibitor PI 71 phase IIa clinical 71 ADP receptor antagonist 71 PREZISTA r 71 ponatinib 71 nucleoside analog 71 Factor VIIa 71 ulimorelin 71 Xeloda ® 70 OvaRex ® MAb 70 huC# DM4 70 sorafenib Nexavar 70 LibiGel ® 70 HCV protease inhibitor 70 methylnaltrexone bromide 70 MEK inhibitor 70 TYGACIL 70 AVONEX ® 70 evaluating satraplatin 70 Phase #b/#a 70 ruxolitinib 70 PEGylated Fab fragment 70 leukemia AML 70 Seliciclib 70 interferon gamma 1b 70 Myocet 70 eltrombopag 70 FUSILEV enhances 70 Pivotal Phase III 70 subcutaneous formulation 70 Triapine R 70 erlotinib Tarceva ® 70 celgosivir 70 TTF Therapy 70 AGILECT R 70 sitaxsentan 70 teduglutide 70 Dapagliflozin 70 cMET 70 dirucotide MBP# 70 diabetic neuropathic pain 70 treatment naïve genotype 70 relapsed multiple myeloma 70 TLK# 70 TOCOSOL Paclitaxel 70 ARCALYST 70 Golimumab 70 PRT# 70 compound INCB# 70 phase IIb study 70 fosbretabulin 70 SNT MC# 70 cell lymphoma CTCL 70 Alzhemed TM 70 novel histone deacetylase 70 Quinamed 70 Tyrima 70 Evoltra ® 70 Cloretazine ® 70 ara C 70 DDP# 70 corticosteroid dexamethasone 70 cannabinor 70 dose cohorts 70 Aloxi injection 70 immunotherapeutic vaccine 70 octreotide LAR 70 teriflunomide 70 Genasense ® 70 lenalidomide Revlimid R 70 miconazole Lauriad ® 70 KRAS mutations occur 70 BRIM3 70 Inhalation Solution 70 Afatinib 70 aflibercept VEGF Trap 70 diarrhea predominant irritable 70 lesinurad 70 MOVIPREP R 70 ALN TTR 70 CBLC# 70 Phase #/#a trial 70 BrachySil TM 70 Phase 1a clinical 70 Omacetaxine 70 vandetanib 70 ketolide antibiotic 70 paclitaxel Taxol R 70 herpetic keratitis 70 custirsen 70 docetaxel chemotherapy 70 telaprevir VX 70 oxymorphone ER 70 cancer neuroendocrine tumor 70 Vicinium TM 70 dexanabinol 70 standard chemotherapy regimen 70 ZYBRESTAT 70 bicifadine 70 ritonavir boosted 70 lintuzumab 70 SinuNase TM 70 MYCAMINE 70 Pafuramidine 70 PI3K/Akt pathway inhibitor 70 Anturol TM 70 MEK Inhibitor 70 ThermoDox R 70 randomized Phase IIb 70 PEGylated interferon beta 1a 70 GVAX ® 70 Raptiva ® 70 alemtuzumab Campath 70 administered intranasally 70 apricitabine 70 goserelin 70 posaconazole 70 thalidomide Thalomid 70 APTIVUS r 70 Protexia ® 70 pharmacokinetic PK study 70 Lixivaptan 70 Ceflatonin 70 APPRAISE 70 relapsed refractory multiple myeloma 70 including eniluracil ADH 70 AQ4N 70 AZILECT ® 70 FOLFOX6 chemotherapy regimen 70 Exherin TM 70 ARCALYST ® 70 dopamine partial agonist 70 RhuDex ® 69 Copegus ribavirin 69 hepatitis C protease inhibitor 69 mitoxantrone plus 69 Capesaris 69 Maribavir 69 omega interferon 69 metastatic GIST 69 Cloretazine R VNP#M 69 pan histone deacetylase 69 Vicriviroc 69 plus prednisone prednisolone 69 axitinib 69 RLY# 69 investigational monoclonal antibody 69 cediranib 69 BCR ABL inhibitor 69 recurrent metastatic 69 Phase 2a clinical trials 69 ENMD # 69 TYSABRI natalizumab 69 refractory CLL 69 administered subcutaneously 69 hormone LHRH antagonist 69 LEUKINE 69 anticancer compound 69 dasatinib Sprycel ® 69 Azilect ® 69 DU #b 69 Azedra 69 Annamycin 69 tezampanel NGX# 69 cetuximab Erbitux 69 Vandetanib 69 synthetic retinoid 69 octreotide implant 69 leading oral taxane 69 Prestara 69 sodium thiosulfate STS 69 Fludara 69 aripiprazole Abilify 69 CINTREDEKIN BESUDOTOX 69 HGS ETR1 mapatumumab 69 Xyfid TM 69 PEG PAL 69 rilonacept 69 clevidipine 69 AEGR 69 evaluating Actimmune 69 tezampanel 69 Intravenous CP 69 SUTENT ® 69 oral FTY# 69 de novo kidney transplant 69 multicenter Phase II 69 AAG geldanamycin analog 69 XL# SAR# 69 OvaRex R 69 demonstrated antitumor activity 69 pan HDAC inhibitor 69 reslizumab 69 Pimavanserin 69 BARACLUDE R 69 im peramivir 69 SUPPRELIN R LA 69 post herpetic neuralgia PHN 69 IMiDs ® 69 radezolid 69 squalamine 69 azilsartan medoxomil 69 sapacitabine CYC# 69 Ketotransdel TM 69 Oracea TM 69 oral picoplatin 69 NGX# 69 NVA# 69 selective S#P# receptor agonist 69 CYCLOSET 69 pegfilgrastim 69 weekly subcutaneous injections 69 atacicept 69 initiated Phase Ib 69 Phenoptin 69 obatoclax 69 selective modulator 69 kidney urologic 69 Solazed 69 Mipomersen 69 albinterferon alfa 2b 69 oxaliplatin Eloxatin 69 CLORETAZINE TM VNP#M 69 orally inhaled 69 Alocrest 69 ISTODAX 69 Genz # 69 RANK Ligand inhibitor 69 Phase 2a clinical 69 Dasatinib 69 Dual Opioid 69 HER2 positive metastatic breast 69 baminercept 69 Vidaza azacitidine 69 Insulin PH# 69 apricitabine ATC 69 forodesine hydrochloride 69 Androxal TM 69 oral talactoferrin 69 Romidepsin 69 octreotide acetate 69 AVASTIN 69 salmeterol fluticasone 69 perampanel 69 cariprazine 69 telomerase therapeutic 69 Pemetrexed 69 Targretin capsules 69 Glufosfamide 69 pegylated interferons 69 LymphoStat B 69 NP2 Enkephalin 69 Zytiga 69 pegylated interferon alpha 69 Xanafide 69 Neulasta ® 69 radiation sensitizer 69 Asentar 69 SUCCEED trial 69 TPI ASM8 69 dasatinib Sprycel 69 Viramidine 69 Cleviprex TM clevidipine 69 hour bronchodilation 69 sargramostim 69 RSD# oral 69 ALGRX 69 Velcade bortezomib 69 PROSTVAC VF 69 Cethromycin 69 Proquin XR 69 metastatic HRPC 69 Pegasys peginterferon alfa 2a 69 recurrent glioblastoma 69 QLT# 69 EOquin 69 RAPTIVA 69 virus HCV infection 69 KNS # 69 immune modulating 69 Raptiva R 69 targeted radiotherapeutic 69 relapsed CLL 69 Initiates Phase II 69 Initiate Phase 69 refractory cutaneous T 69 oral renin inhibitor 69 panitumumab Vectibix 69 systemic ALCL 69 aplindore 69 FASLODEX 69 refractory CTCL 69 Octreolin 69 MGCD# [001] 69 GRN# 69 APTIVUS ritonavir 69 Proxinium TM 69 RELOVAIR ™ 69 CCX# B 69 orally bioavailable 69 verteporfin 69 CCR5 antagonist 69 Actimmune ® 69 tolevamer 69 Nanobody 69 eosinophilic asthma 69 Tasimelteon 69 CYC# 69 Genasense oblimersen sodium Injection 69 GW# [003] 69 faropenem 69 JNJ Q2 69 Temsirolimus 69 IL# PE#QQR 69 estramustine 69 SAR# [004] 69 Personalized Immunotherapy 69 UPLYSO 69 histone deacetylase HDAC inhibitor 69 Sudhir Agrawal D.Phil 69 anthracycline taxane 69 rhIGF-I/rhIGFBP-3 69 recurrent metastatic ovarian cancer 69 Safinamide 69 Nexavar ® 69 TRO# 68 TELCYTA 68 DermaVir Patch 68 BENLYSTA TM 68 Begins Dosing 68 telomerase inhibitor drug 68 JAK inhibitors 68 Mitoxantrone 68 KRN# 68 INSPIRE Trial Phase III 68 multi kinase inhibitor 68 depsipeptide 68 Cetrorelix 68 oropharyngeal candidiasis OPC 68 Phase Ib clinical 68 Amigal 68 Tamibarotene 68 xanthine oxidase inhibitor 68 MAXY G# 68 dalbavancin 68 investigational humanized monoclonal antibody 68 Q#IR 68 IRX 2 68 lapatinib Tykerb 68 paclitaxel poliglumex 68 ISENTRESS 68 ongoing Phase 1b 68 tenofovir emtricitabine 68 certolizumab 68 dosing cohort 68 Aplidin 68 Pegloticase 68 BLA filing 68 Xcytrin R 68 CHOP chemotherapy 68 PRADAXA 68 Aurora kinase inhibitor 68 Triapine 68 elagolix 68 inecalcitol 68 investigational oral inhibitor 68 IMC A# 68 Tiuxetan 68 Sprycel dasatinib 68 PhG alpha 1 68 Tesetaxel 68 MKC# MT 68 ChronVac C R 68 Phase 2b study 68 urocortin 2 68 SNT-MC#/idebenone 68 HuLuc# 68 metastatic CRC 68 R roscovitine 68 metastatic castration resistant 68 orally inhaled migraine 68 toenail onychomycosis 68 Phase Ib IIa 68 dirucotide 68 RezularTM 68 DEB# 68 Azedra TM 68 VEGFR2 inhibitor 68 Phase 2b Clinical Trial 68 oral nucleoside analogue 68 angiogenesis inhibitor 68 monoclonal antibody conjugated 68 Panzem 68 Twinrix 68 active comparator 68 non nucleoside HCV 68 mRCC 68 NXL# 68 integrin inhibitor 68 Tezampanel 68 Alferon N 68 novel oral anticoagulant 68 Aptivus ® 68 CD# CEA 68 registrational 68 Mg Usa 68 pemphigus vulgaris 68 Cinryze ™ 68 Trofex 68 placebo controlled Phase 68 VELCADE melphalan 68 ceftazidime 68 HCV SPRINT 68 POSIDUR TM 68 R#/MEM 68 severe hypercholesterolemia 68 initiate Phase 1b 68 retinal vein occlusion induced 68 liposomal formulation 68 Microplasmin 68 assessing T DM1 68 HCV RESPOND 2 68 pegylated interferon alfa 2a 68 investigational protease inhibitor 68 TKM ApoB 68 REMINYL ® 68 hereditary deficiency 68 glufosfamide 68 drug ISA# 68 systemically administered 68 lexidronam injection 68 immunotherapeutic agent 68 ACOMPLIA R 68 AMEVIVE 68 lucinactant 68 ® natalizumab 68 rasagiline tablets 68 ospemifene 68 GLPG# 68 ofatumumab 68 rNAPc2 68 TO AVOID PREGNANCY WHILE 68 IMiDs ® compound 68 Rebif ® 68 Cytoxan 68 sapacitabine 68 EMSAM 68 inhaled formulation 68 MyVax R 68 Degarelix 68 subcutaneous PRO 68 pain palliation 68 vicriviroc 68 alvimopan 68 sodium Injection 68 Laquinimod 68 Aryplase 68 Meets Primary Endpoint 68 nab paclitaxel 68 cisplatin gemcitabine 68 Kepivance 68 formerly LymphoStat B 68 epoetin alpha 68 Gemzar ® 68 TORISEL 68 oxypurinol 68 intermittent dosing 68 refractory metastatic 68 Sym# 68 MabThera Rituxan 68 ALVESCO HFA 68 renin inhibitor 68 reduce serum phosphate 68 BRAF inhibitor 68 Hepatocellular Carcinoma HCC 68 anti TNF alpha 68 oral antiviral 68 ISIS # 68 midstage clinical 68 CRLX# 68 inhaled liposomal ciprofloxacin 68 trastuzumab DM1 68 LUX Lung 68 otelixizumab 68 2 methoxyestradiol 68 volociximab 68 UVIDEM 68 JAK2 inhibitor 68 AKT inhibitor 68 incyclinide 68 HBeAg negative 68 IMiDs R 68 DOXIL 68 LEVADEX ™ 68 Phase 2b clinical 68 Phase IIa trial 68 ® bortezomib 68 fostamatinib 68 Achieves Primary Endpoint 68 ABILIFY ® 68 daptomycin 68 Arikace 68 FOLOTYN 68 motesanib 68 TREANDA 68 ibandronate 68 catheter occlusion 68 metastatic sarcomas 68 GVAX R 68 etanercept Enbrel 68 candidate CRLX# 68 Genasense ® oblimersen 68 Sapacitabine 68 OMNARIS Nasal Spray 68 5 fluorouracil leucovorin 68 systemic anaplastic large 68 Initiate Clinical Trial 68 generation PNP inhibitor 68 decitabine 68 crizotinib PF # 68 Betaferon R 68 hoFH 68 investigational immunotherapy 68 ixabepilone 68 tramiprosate Alzhemed TM 68 trastuzumab Herceptin R 68 Campath alemtuzumab 68 ZD# [001] 68 Peginterferon 68 Hedgehog antagonist 68 ADVANCE PD 68 Epothilone D 68 PEGylated interferon 68 trastuzumab Herceptin ® 68 investigational hepatitis C 68 generation NNRTI 68 cetuximab Erbitux R 68 Jevtana 68 OMP #R# 68 INCB# [002] 68 inhalation powder 68 LY# [003] 68 dextromethorphan quinidine 68 TASKi3 68 dacetuzumab 68 Combination REOLYSIN R 68 Abiraterone acetate 68 oncolytic virus therapies 68 Zorbtive TM 68 farletuzumab 68 Phase 1b 68 Troxatyl 68 Kuvan R 68 ACAPODENE 68 Pegasys ® 68 Femara letrozole 68 IIa trial 68 vinca alkaloid 68 delivers fluocinolone acetonide FA 68 Cimzia ® certolizumab pegol 68 Immunotherapeutic 68 anti EGFR antibody 68 inhaled AAT 68 Poly ICLC 68 hypereosinophilic syndrome 68 taribavirin 68 alefacept 68 5 lipoxygenase inhibitor 68 IMiDs 68 5 FU leucovorin 68 PEG Interferon lambda 68 INTEGRILIN ® 68 AZX# 68 nalbuphine ER 68 evaluating picoplatin 68 tubulin inhibitor 68 myopathy rhabdomyolysis 68 letrozole Femara 68 Zerenex 68 EndoTAG TM -1 68 uric acid lowering 68 Xibrom TM 68 investigational oral hepatitis C 68 Luteinizing Hormone Releasing Hormone 68 bosutinib 68 Prulifloxacin 68 ozarelix 68 Diamyd ® 68 Irinotecan 68 BARACLUDE ® 68 zanolimumab 68 DIFICID ™ 68 amrubicin 68 ONCASPAR 68 romidepsin 68 PD LID 67 refractory APL 67 CRD5 67 Symadex 67 Canvaxin 67 myelodysplastic myeloproliferative diseases 67 tarenflurbil 67 Interferon alpha 67 ARCOXIA 67 REMUNE R 67 AZOR 67 CytoFabTM 67 GetGoal Phase III 67 Oral NKTR 67 EFFEXOR XR 67 Nexavar sorafenib 67 null responder 67 mGluR5 NAM 67 Mg Uk 67 low dose cytarabine 67 RRMS patients 67 heavily pretreated 67 Completes Patient Enrollment 67 8mg/kg 67 Tarvacin TM 67 adecatumumab MT# 67 EVIZON 67 Pertuzumab 67 Uricase PEG 67 EDEMA3 67 pharmacologically active isomer 67 evaluating mipomersen 67 BEXXAR 67 mGluR5 negative 67 AeroLEF TM 67 Fx #A 67 DACH platinum 67 huN# DM1 67 Ambrisentan 67 Simulect 67 null responder HCV 67 superficial bladder cancer 67 ATL/TV# 67 Plenaxis TM 67 aflibercept 67 CINQUIL 67 Darinaparsin 67 ZADAXIN ® 67 Frova ® 67 denileukin diftitox 67 Icatibant 67 TRISENOX 67 Phase IIa trials 67 methylnaltrexone 67 plasma kallikrein inhibitor 67 GRNVAC1 67 Dextofisopam 67 XL# XL# XL# XL# 67 SCH # 67 PRISTIQ 67 PLK1 SNALP 67 Naive Patients 67 HCl Tablets 67 acute mania 67 biologic DMARD 67 Increlex ® 67 Serdolect ® 67 Panzem ® 67 PrevOnco ™ 67 lead Aganocide compound 67 Xelox 67 Aptivus 67 human IgG1 monoclonal 67 diabetic gastroparesis 67 non metastatic osteosarcoma 67 GLYX 67 CAELYX 67 adefovir dipivoxil 67 investigational therapies 67 phase IIa 67 HDL Selective Delipidation 67 Bayer HealthCare Onyx Pharmaceuticals 67 Phase III Pivotal 67 EGFR TKI 67 TNF Tumor Necrosis Factor 67 nucleoside reverse transcriptase inhibitor 67 Virulizin R 67 TYZEKA 67 XL# XL# 67 ancrod 67 phase IIb III 67 Pivotal Phase 67 Fludara ® 67 ACAPODENE TM 67 FOR FURTHER INFORMATION ABOUT 67 Voraxaze ™ 67 alpha interferons 67 dose escalation trial 67 atrasentan 67 elacytarabine 67 levocetirizine 67 PSN# [002] 67 Gamunex C 67 BUPHENYL R 67 rALLy 67 Blinatumomab 67 FDA APPROVES 67 abacavir lamivudine 67 OXi# 67 thymalfasin 67 bortezomib Velcade R 67 Peg IFN 67 Metastatic Melanoma 67 Urocidin 67 Vitaxin 67 Curaxin CBLC# 67 Amgen Neulasta ® 67 Initiates Phase III 67 Entereg R 67 bortezomib Velcade 67 irinotecan chemotherapy 67 Elotuzumab 67 esophageal candidiasis 67 Noxafil 67 rFIXFc 67 Somatuline Depot 67 Torisel 67 placebo controlled clinical 67 corticosteroid dose 67 MyVax ® 67 anthracyclines taxanes 67 casopitant 67 Vidofludimus 67 TG# [003] 67 Thiovir 67 indolent NHL 67 CORT # 67 TACI Ig 67 Voreloxin 67 SinuNase ™ 67 pregabalin Lyrica 67 castrate resistant prostate cancer 67 HoFH 67 SUTENT 67 PEGylated anti 67 Prodarsan R 67 investigational oral 67 Natalizumab 67 Telintra 67 Darusentan 67 MAA submission 67 EP #R 67 Benlysta belimumab 67 NATRECOR R 67 phase 2a 67 oral antidiabetic medication 67 NUVIGIL 67 SCIg 67 Phase Ib 67 Talabostat 67 HuMax TAC 67 RGB # 67 candidate XP# 67 ZK EPO 67 CDP# 67 Pyridorin 67 KAPVAY ™ 67 vapreotide acetate 67 carboplatin paclitaxel 67 gemifloxacin 67 RDEA# 67 pitavastatin 67 Hedgehog Pathway Inhibitor 67 MYDICAR 67 Gel repository corticotropin injection 67 CANCIDAS 67 advanced carcinoid 67 Deforolimus 67 resminostat 67 non splenectomized 67 antiangiogenic therapy 67 Arranon 67 Silodosin 67 Alvesco R 67 metastatic colorectal carcinoma 67 TASKi2 67 BROVANA 67 oral ghrelin agonist 67 REMICADE ® 67 Gabapentin GR 67 PRX # 67 humanised monoclonal antibody 67 systemic immunosuppressive drugs 67 IV Busulfex 67 therapeutic monoclonal antibody 67 BCR ABL inhibitors 67 ProSavin 67 Pharmacokinetics PK 67 glucokinase activator 67 mycophenolate mofetil 67 LHRH antagonists 67 ganaxolone 67 bendamustine 67 BRAF V# mutation 67 oral iron chelator 67 MEK inhibitors 67 APEX PD 67 desvenlafaxine succinate 67 Pegylated Interferon 67 NEBIDO 67 Neupogen ® 67 REBETOL combination therapy 67 cobiprostone